AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: A phase 3 randomised trial

Janet E. McElhaney, Jiri Beran, Jeanne Marie Devaster, Meral Esen, Odile Launay, Geert Leroux-Roels, Guillermo M. Ruiz-Palacios, Gerrit A. van Essen, Adrian Caplanusi, Carine Claeys, Christelle Durand, Xavier Duval, Mohamed El Idrissi, Ann R. Falsey, Gregory Feldman, Sharon E. Frey, Florence Galtier, Shinn Jang Hwang, Bruce L. Innis, Martina KovacPeter Kremsner, Shelly McNeil, Andrzej Nowakowski, Jan Hendrik Richardus, Andrew Trofa, Lidia Oostvogels

Research output: Contribution to journalArticlepeer-review

139 Citations (Scopus)
Original languageEnglish
Pages (from-to)485-496
Number of pages12
JournalThe Lancet Infectious Diseases
Volume13
Issue number6
DOIs
Publication statusPublished - Jun 2013

ASJC Scopus Subject Areas

  • Infectious Diseases

Fingerprint

Dive into the research topics of 'AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: A phase 3 randomised trial'. Together they form a unique fingerprint.

Cite this